tomtull@Eng.Sun.COM (Tom Tull) (12/08/90)
There was some "positive news" for people that are HIV+
last night at a meeting I attended at the San Francisco Medical
Association sponsored by BETA, a publication of the SF AIDS
Foundation.
The "positive news" is that with the use of "old" drugs that
cost a lot less and are a lot easier to administer than Aerosolized
Pentamidine (AP) an initial PCP "breakthrough" can almost be eliminated
using a PCP prophylaxis of Septra/Bactrim, Trimethoprim-dapsone or
Fansidar. Thus initial and secondary bouts of PCP, which is the leading
cause of death in HIV+ people, can be prevented to a much larger degree
than with AP for people that can tolerate the above mentioned drugs.
AP is very "trendy" but, it was suggested, not as effective
as the "old" cheaper drugs in preventing a PCP breakthrough.
Cheers,
tt
--
---
Tom Tull ARPA: tomtull@bourbon.sun.com
Sun Microsystems Inc. UUCP: {most US backbones}!sun!bourbon!tomtull
Work: 415-336-0412 Home: 415-334-3233 or 289 Gambier St., SF 94134